Diabetes hastens progression of preclinical heart failure

Clutching chest due to heart attack

Author: Eleanor McDermid medwireNews: The presence of diabetes in people with preclinical heart failure (HF) shortens the time to a first clinical event, especially if blood glucose is poorly controlled, show data from the ARIC study. “Our results suggest that targeting diabetes early in the HF process is critical,” write Justin Echouffo-Tcheugui (Johns Hopkins University, […]

Researchers calculate unannounced snack threshold for closed-loop system

Young diabetic patient with insulin pump

Author: Laura Cowen medwireNews: Children and adolescents using an advanced hybrid closed-loop system (a-HCL) for type 1 diabetes can tolerate an unannounced snack containing 20 g of carbohydrate without excessive blood sugar fluctuations, Italian researchers report. Daniela Nisticò (University of Trieste) and colleagues say their findings “may be particularly helpful for children who are still not […]

Corticosteroid treatment and the consequences for glucose control

Author: John Wilding The clinical challenge Glucocorticoids, which include long-acting corticosteroid preparations such as prednisolone and dexamethasone, are frequently used to treat inflammatory conditions such as asthma and exacerbations of chronic obstructive pulmonary disease, and other conditions including many autoimmune diseases, and also to reduce cerebral edema in association with brain tumors. More recently, the […]

Time to reconsider the person with shortness of breath: EMPEROR-Preserved Recorded: Monday, October 11, 2021Broadcast: Thursday, October 21, 2021 Meet the faculty Alice Cheng Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto. Lars Rydén (Chair) Lars Rydén is Senior Professor of Cardiology at the Karolinska Institute, Stockholm, Sweden. He is […]

Management of type 1 diabetes: ADA/EASD consensus report

Anne Peters talks about the goals of the ADA/EASD type 1 diabetes management consensus report, the issues to urgently address, and the joys of being part of a trans-Atlantic collaboration (9:53). 0:00 – The goals of the report0:53 – The importance of psychosocial care3:35 – Are providers ready for routine use of technology?4:30 – Type […]

DKD treatment update: SGLT2 inhibitors and finerenone

Nephrologist Ian de Boer joins primary care physician Amrit Lamba to discuss how the recent approval of finerenone and extension of the dapagliflozin label is likely to influence the treatment of kidney disease in people with type 2 diabetes. 0:00 Introduction 1:40 The DAPA-CKD trial: Building on CREDENCE 5:01 How the trial findings will influence primary care 7:10 Safety […]

Suicide in diabetes: An important but under-recorded problem

The FDA has recently highlighted the elevated risk for suicide in people with diabetes, resulting in the creation of the REducing SuiCide rates amongst individUals with diabEtes (RESCUE) Collaborative Community to examine issues relating to the identification and management of increased suicide risk in people with diabetes. In this brief overview, we look at the […]